Acid-reducing medication for esophagus protection during lung radiation
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests whether taking a daily acid-reducing medication (a PPI, like omeprazole) during radiation for lung cancer can protect your food pipe (esophagus) from irritation. The goal is to reduce discomfort like pain or difficulty swallowing caused by radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have lung cancer (any type or stage, as confirmed by your doctor).
- You are scheduled to receive radiation at a dose of at least 40 gray over 15 sessions (or an equivalent).
- You have not taken acid-reducing medications (like omeprazole, pantoprazole, esomeprazole) in the past 3 months.
- You are willing to take this kind of medication daily during your radiation treatment.
- You do not have painful swallowing before starting the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.
This study looks at how chest radiation treatment affects the heart and lungs in people with certain lung or esophagus cancers. It may help doctors better predict and prevent these side effects during curative (aimed at cure) radiotherapy.
This trial tests a new drug that helps the immune system fight cancer, combined with a special type of radiation therapy, for people with esophageal, lung, or cervical cancer that has progressed after initial treatment.
This trial studies whether adding propranolol (a common blood-pressure/heart medication) to standard chemotherapy and radiation can improve outcomes for people with esophageal adenocarcinoma. You would start propranolol around the time of treatment, with careful heart monitoring and study follow-up.
This study tests whether a common heartburn medicine (esomeprazole) can help prevent or reduce painful swallowing caused by radiation for lung cancer. If you have stage 3 non-small cell lung cancer and are getting chemo and chest radiation, you may be able to join.
This trial studies whether proton therapy can better treat early-to-mid stage esophagus cancer while aiming to reduce side effects to nearby organs. Proton therapy uses a targeted type of radiation, and participants are also checked to be eligible for curative surgery.
Hear when a new Non Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.